MJ

Manish Jain

Chief Technology Officer

Thymmune Therapeutics

Thymmune Therapeutics Pipeline

DrugIndicationPhase
Platform-derived thymic cell therapyImmune dysfunction in aging and disease (Immunodeficiencies, Transplant-related, Autoimmune)Pre-clinical